相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A phase I/II study of Pexa-Vec oncolytic virus in combination with immune checkpoint inhibition in refractory colorectal cancer.
M. Cecilia Monge B. et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
In Vivo CD4(+) T Cell Differentiation and Function: Revisiting the Th1/Th2 Paradigm
Mikel Ruterbusch et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)
Engineered Cell-Membrane-Coated Nanoparticles Directly Present Tumor Antigens to Promote Anticancer Immunity
Yao Jiang et al.
ADVANCED MATERIALS (2020)
Vaccination of aged mice with adjuvanted recombinant influenza nucleoprotein enhances protective immunity
Tres Cookenham et al.
VACCINE (2020)
NIR-Triggered Phototherapy and Immunotherapy via an Antigen-Capturing Nanoplatform for Metastatic Cancer Treatment
Meng Wang et al.
ADVANCED SCIENCE (2019)
Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination
Linda Hammerich et al.
NATURE MEDICINE (2019)
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
Filipe Martins et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Deletion of Apoptosis Inhibitor F1L in Vaccinia Virus Increases Safety and Oncolysis for Cancer Therapy
Adrian Pelin et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Mild photothermal therapy potentiates anti-PD-L1 treatment for immunologically cold tumors via an all-in-one and all-in-control strategy
Liping Huang et al.
NATURE COMMUNICATIONS (2019)
In situ vaccination with biocompatibility controllable immuno-sensitizer inducing antitumor immunity
Heejun Shin et al.
BIOMATERIALS (2019)
Surface-Functionalized Modified Copper Sulfide Nanoparticles Enhance Checkpoint Blockade Tumor Immunotherapy by Photothermal Therapy and Antigen Capturing
Ruoping Wang et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
STING activation in cancer immunotherapy
Ting Su et al.
THERANOSTICS (2019)
Combinatorial library of chalcogen-containing lipidoids for intracellular delivery of genome-editing proteins
Yamin Li et al.
BIOMATERIALS (2018)
SnapShot: cGAS-STING Signaling
Lorenzo Galluzzi et al.
CELL (2018)
Personalized vaccines for cancer immunotherapy
Ugur Sahin et al.
SCIENCE (2018)
Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer
Jutaek Nam et al.
NATURE COMMUNICATIONS (2018)
In Situ Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma
Matthew J. Frank et al.
CANCER DISCOVERY (2018)
NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines
Nadine van Montfoort et al.
CELL (2018)
Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy
Matthias A. Oberli et al.
NANO LETTERS (2017)
A STING-activating nanovaccine for cancer immunotherapy
Min Luo et al.
NATURE NANOTECHNOLOGY (2017)
Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy
Yuanzeng Min et al.
NATURE NANOTECHNOLOGY (2017)
Ester alkaloids from Cephalotaxus interfere with the 2'3'-cGAMP-induced type I interferon pathway in vitro
Gayoung Park et al.
PLOS ONE (2017)
In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments
Zachary S. Morris et al.
CANCER RESEARCH (2016)
The host STING pathway at the interface of cancer and immunity
Leticia Corrales et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Expediting Viral Therapies for Cancers to the Clinic
Yuman Fong
MOLECULAR THERAPY (2016)
Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles
Ming Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
Qian Chen et al.
NATURE COMMUNICATIONS (2016)
Therapeutic cancer vaccines
Cornelis J. M. Melief et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
In situ vaccination: Cancer immunotherapy both personalized and off-the-shelf
Linda Hammerich et al.
MOLECULAR ONCOLOGY (2015)
Reactive Oxygen Species-Responsive Protein Modification and Its Intracellular Delivery for Targeted Cancer Therapy
Ming Wang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Therapeutic vaccines for cancer: an overview of clinical trials
Ignacio Melero et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Systemic delivery of a TLR7 agonist in combination with radiation primes durable antitumor immune responses in mouse models of lymphoma
Simon J. Dovedi et al.
BLOOD (2013)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
Virus-cell fusion as a trigger of innate immunity dependent on the adaptor STING
Christian K. Holm et al.
NATURE IMMUNOLOGY (2012)
In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study
Joshua D. Brody et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Alum adjuvanticity: Unraveling a century old mystery
Ennio De Gregorio et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Calreticulin exposure dictates the immunogenicity of cancer cell death
Michel Obeid et al.
NATURE MEDICINE (2007)
Electroporation as a prime/boost strategy for naked DNA vaccination against a tumor antigen
S Buchan et al.
JOURNAL OF IMMUNOLOGY (2005)
Fighting cancer with vaccinia virus: Teaching new tricks to an old dog
YQ Shen et al.
MOLECULAR THERAPY (2005)
分享论文
